Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Lung Cancer Liquid Biopsy Product Introduction
1.2 Global Lung Cancer Liquid Biopsy Market Size Forecast
1.3 Lung Cancer Liquid Biopsy Market Trends & Drivers
1.3.1 Lung Cancer Liquid Biopsy Industry Trends
1.3.2 Lung Cancer Liquid Biopsy Market Drivers & Opportunity
1.3.3 Lung Cancer Liquid Biopsy Market Challenges
1.3.4 Lung Cancer Liquid Biopsy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lung Cancer Liquid Biopsy Players Revenue Ranking (2023)
2.2 Global Lung Cancer Liquid Biopsy Revenue by Company (2019-2024)
2.3 Key Companies Lung Cancer Liquid Biopsy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Lung Cancer Liquid Biopsy Product Offered
2.5 Key Companies Time to Begin Mass Production of Lung Cancer Liquid Biopsy
2.6 Lung Cancer Liquid Biopsy Market Competitive Analysis
2.6.1 Lung Cancer Liquid Biopsy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Lung Cancer Liquid Biopsy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Exosomes and RNA
3.1.2 CTCs and ctDNA
3.2 Global Lung Cancer Liquid Biopsy Sales Value by Type
3.2.1 Global Lung Cancer Liquid Biopsy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lung Cancer Liquid Biopsy Sales Value, by Type (2019-2030)
3.2.3 Global Lung Cancer Liquid Biopsy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Lung Cancer Liquid Biopsy Sales Value by Application
4.2.1 Global Lung Cancer Liquid Biopsy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lung Cancer Liquid Biopsy Sales Value, by Application (2019-2030)
4.2.3 Global Lung Cancer Liquid Biopsy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Lung Cancer Liquid Biopsy Sales Value by Region
5.1.1 Global Lung Cancer Liquid Biopsy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lung Cancer Liquid Biopsy Sales Value by Region (2019-2024)
5.1.3 Global Lung Cancer Liquid Biopsy Sales Value by Region (2025-2030)
5.1.4 Global Lung Cancer Liquid Biopsy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Lung Cancer Liquid Biopsy Sales Value, 2019-2030
5.2.2 North America Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Lung Cancer Liquid Biopsy Sales Value, 2019-2030
5.3.2 Europe Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Lung Cancer Liquid Biopsy Sales Value, 2019-2030
5.4.2 Asia Pacific Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Lung Cancer Liquid Biopsy Sales Value, 2019-2030
5.5.2 South America Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Lung Cancer Liquid Biopsy Sales Value, 2019-2030
5.6.2 Middle East & Africa Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value
6.3 United States
6.3.1 United States Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.3.2 United States Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.4.2 Europe Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.5.2 China Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.6.2 Japan Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.7.2 South Korea Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.8.2 Southeast Asia Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lung Cancer Liquid Biopsy Sales Value, 2019-2030
6.9.2 India Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lung Cancer Liquid Biopsy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 RainDanceTechnologies
7.1.1 RainDanceTechnologies Profile
7.1.2 RainDanceTechnologies Main Business
7.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Products, Services and Solutions
7.1.4 RainDanceTechnologies Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.1.5 RainDanceTechnologies Recent Developments
7.2 Biocartis
7.2.1 Biocartis Profile
7.2.2 Biocartis Main Business
7.2.3 Biocartis Lung Cancer Liquid Biopsy Products, Services and Solutions
7.2.4 Biocartis Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.2.5 Biocartis Recent Developments
7.3 Qiagen
7.3.1 Qiagen Profile
7.3.2 Qiagen Main Business
7.3.3 Qiagen Lung Cancer Liquid Biopsy Products, Services and Solutions
7.3.4 Qiagen Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.3.5 Guardant Health Recent Developments
7.4 Guardant Health
7.4.1 Guardant Health Profile
7.4.2 Guardant Health Main Business
7.4.3 Guardant Health Lung Cancer Liquid Biopsy Products, Services and Solutions
7.4.4 Guardant Health Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.4.5 Guardant Health Recent Developments
7.5 MDxHealth
7.5.1 MDxHealth Profile
7.5.2 MDxHealth Main Business
7.5.3 MDxHealth Lung Cancer Liquid Biopsy Products, Services and Solutions
7.5.4 MDxHealth Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.5.5 MDxHealth Recent Developments
7.6 Pathway Genomics
7.6.1 Pathway Genomics Profile
7.6.2 Pathway Genomics Main Business
7.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Products, Services and Solutions
7.6.4 Pathway Genomics Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.6.5 Pathway Genomics Recent Developments
7.7 NeoGenomics Laboraories
7.7.1 NeoGenomics Laboraories Profile
7.7.2 NeoGenomics Laboraories Main Business
7.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Products, Services and Solutions
7.7.4 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.7.5 NeoGenomics Laboraories Recent Developments
7.8 Sysmex Inostics
7.8.1 Sysmex Inostics Profile
7.8.2 Sysmex Inostics Main Business
7.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Products, Services and Solutions
7.8.4 Sysmex Inostics Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.8.5 Sysmex Inostics Recent Developments
7.9 Cynvenio
7.9.1 Cynvenio Profile
7.9.2 Cynvenio Main Business
7.9.3 Cynvenio Lung Cancer Liquid Biopsy Products, Services and Solutions
7.9.4 Cynvenio Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.9.5 Cynvenio Recent Developments
7.10 Menarini Silicon Biosystems
7.10.1 Menarini Silicon Biosystems Profile
7.10.2 Menarini Silicon Biosystems Main Business
7.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Products, Services and Solutions
7.10.4 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.10.5 Menarini Silicon Biosystems Recent Developments
7.11 Adaptive Biotechnologies
7.11.1 Adaptive Biotechnologies Profile
7.11.2 Adaptive Biotechnologies Main Business
7.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Products, Services and Solutions
7.11.4 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.11.5 Adaptive Biotechnologies Recent Developments
7.12 Biocept
7.12.1 Biocept Profile
7.12.2 Biocept Main Business
7.12.3 Biocept Lung Cancer Liquid Biopsy Products, Services and Solutions
7.12.4 Biocept Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.12.5 Biocept Recent Developments
7.13 Angle plc
7.13.1 Angle plc Profile
7.13.2 Angle plc Main Business
7.13.3 Angle plc Lung Cancer Liquid Biopsy Products, Services and Solutions
7.13.4 Angle plc Lung Cancer Liquid Biopsy Revenue (US$ Million) & (2019-2024)
7.13.5 Angle plc Recent Developments
8 Industry Chain Analysis
8.1 Lung Cancer Liquid Biopsy Industrial Chain
8.2 Lung Cancer Liquid Biopsy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lung Cancer Liquid Biopsy Sales Model
8.5.2 Sales Channel
8.5.3 Lung Cancer Liquid Biopsy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Lung Cancer Liquid Biopsy Market Trends
Table 2. Lung Cancer Liquid Biopsy Market Drivers & Opportunity
Table 3. Lung Cancer Liquid Biopsy Market Challenges
Table 4. Lung Cancer Liquid Biopsy Market Restraints
Table 5. Global Lung Cancer Liquid Biopsy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lung Cancer Liquid Biopsy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Lung Cancer Liquid Biopsy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Lung Cancer Liquid Biopsy Product Type
Table 9. Key Companies Time to Begin Mass Production of Lung Cancer Liquid Biopsy
Table 10. Global Lung Cancer Liquid Biopsy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Lung Cancer Liquid Biopsy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Lung Cancer Liquid Biopsy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Lung Cancer Liquid Biopsy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Lung Cancer Liquid Biopsy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Lung Cancer Liquid Biopsy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Lung Cancer Liquid Biopsy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Lung Cancer Liquid Biopsy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Lung Cancer Liquid Biopsy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Lung Cancer Liquid Biopsy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Lung Cancer Liquid Biopsy Sales Value by Region (2019-2024) & (%)
Table 27. Global Lung Cancer Liquid Biopsy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value, (2025-2030) & (US$ Million)
Table 31. RainDanceTechnologies Basic Information List
Table 32. RainDanceTechnologies Description and Business Overview
Table 33. RainDanceTechnologies Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of RainDanceTechnologies (2019-2024)
Table 35. RainDanceTechnologies Recent Developments
Table 36. Biocartis Basic Information List
Table 37. Biocartis Description and Business Overview
Table 38. Biocartis Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Biocartis (2019-2024)
Table 40. Biocartis Recent Developments
Table 41. Qiagen Basic Information List
Table 42. Qiagen Description and Business Overview
Table 43. Qiagen Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Qiagen (2019-2024)
Table 45. Qiagen Recent Developments
Table 46. Guardant Health Basic Information List
Table 47. Guardant Health Description and Business Overview
Table 48. Guardant Health Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Guardant Health (2019-2024)
Table 50. Guardant Health Recent Developments
Table 51. MDxHealth Basic Information List
Table 52. MDxHealth Description and Business Overview
Table 53. MDxHealth Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of MDxHealth (2019-2024)
Table 55. MDxHealth Recent Developments
Table 56. Pathway Genomics Basic Information List
Table 57. Pathway Genomics Description and Business Overview
Table 58. Pathway Genomics Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Pathway Genomics (2019-2024)
Table 60. Pathway Genomics Recent Developments
Table 61. NeoGenomics Laboraories Basic Information List
Table 62. NeoGenomics Laboraories Description and Business Overview
Table 63. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of NeoGenomics Laboraories (2019-2024)
Table 65. NeoGenomics Laboraories Recent Developments
Table 66. Sysmex Inostics Basic Information List
Table 67. Sysmex Inostics Description and Business Overview
Table 68. Sysmex Inostics Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Sysmex Inostics (2019-2024)
Table 70. Sysmex Inostics Recent Developments
Table 71. Cynvenio Basic Information List
Table 72. Cynvenio Description and Business Overview
Table 73. Cynvenio Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Cynvenio (2019-2024)
Table 75. Cynvenio Recent Developments
Table 76. Menarini Silicon Biosystems Basic Information List
Table 77. Menarini Silicon Biosystems Description and Business Overview
Table 78. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Menarini Silicon Biosystems (2019-2024)
Table 80. Menarini Silicon Biosystems Recent Developments
Table 81. Adaptive Biotechnologies Basic Information List
Table 82. Adaptive Biotechnologies Description and Business Overview
Table 83. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Adaptive Biotechnologies (2019-2024)
Table 85. Adaptive Biotechnologies Recent Developments
Table 86. Biocept Basic Information List
Table 87. Biocept Description and Business Overview
Table 88. Biocept Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Biocept (2019-2024)
Table 90. Biocept Recent Developments
Table 91. Angle plc Basic Information List
Table 92. Angle plc Description and Business Overview
Table 93. Angle plc Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Angle plc (2019-2024)
Table 95. Angle plc Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Lung Cancer Liquid Biopsy Downstream Customers
Table 99. Lung Cancer Liquid Biopsy Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Lung Cancer Liquid Biopsy Product Picture
Figure 2. Global Lung Cancer Liquid Biopsy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 4. Lung Cancer Liquid Biopsy Report Years Considered
Figure 5. Global Lung Cancer Liquid Biopsy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Cancer Liquid Biopsy Revenue in 2023
Figure 7. Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Exosomes and RNA Picture
Figure 9. CTCs and ctDNA Picture
Figure 10. Global Lung Cancer Liquid Biopsy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Lung Cancer Liquid Biopsy Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Clinics
Figure 14. Product Picture of Others
Figure 15. Global Lung Cancer Liquid Biopsy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Lung Cancer Liquid Biopsy Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value (%), (2019-2030)
Figure 28. United States Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 34. China Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 36. China Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 46. India Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 48. India Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 49. Lung Cancer Liquid Biopsy Industrial Chain
Figure 50. Lung Cancer Liquid Biopsy Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation